The search uncovered two post-traumatic stress disorder loci in Europeans and a third in individuals with African ancestry, highlighting immune- and brain-related genes.
The analysis further found that the degree of network perturbation correlated with the severity of toddlers' autism spectrum disorder.
The San Diego-based firm has developed a new extracellular RNA sequencing method that it believes could be used for cancer diagnostics.
Researchers warn that there are finite ancient samples for genetic analysis and argue that policies should be in place to ensure they are studied responsibly.
In PNAS this week: transcriptomic and epigenomic sequence differences in glioblastoma models, approach to analyze small amounts of extracellular RNA, and more.
MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.
Two BioRxiv preprints describe new algorithms that the developers say can accelerate the pace of genome analysis.
The $10 million initiative will include scientists from the University of California's campuses, as well as from governmental and nongovernmental organizations.
The Methyl-HiC assay, which combines epigenetic and genome structure analyses, comes from a lab with a history of commercializing tests.
In European American military veterans, the study led to several genetic loci with ties to the severity of a core PTSD symptom known as reexperiencing.
Russian CRISPR researcher moves along with plans to ultimately alter the genes of embryos of deaf couples, though awaits regulatory approval, Nature News reports.
University of California, San Francisco, researchers have uncovered a gene mutations that appears to make a father-son duo more efficient sleepers.
NPR reports a large health insurer has begun to cover some pharmacogenetic tests for psychiatric drugs.
In PLOS this week: genome-wide association study of non-syndromic orofacial cleft subtypes, epigenetic and transcriptomic analysis of pancreatic ductal adenocarcinoma, and more.